<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: Disseminated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells (<z:chebi fb="17" ids="53093">DTCs</z:chebi>) have been associated with clinical outcome in various <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study is to examine the status of <z:chebi fb="17" ids="53093">DTC</z:chebi> in peripheral blood (PB) and bone marrow (BM) of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and to evaluate its clinical significance </plain></SENT>
<SENT sid="2" pm="."><plain>METHODOLOGY: A total of 75 CRC patients treated with radical resection were enrolled in this study </plain></SENT>
<SENT sid="3" pm="."><plain>Nested RT-PCR was used to detect the 2 representative markers of <z:chebi fb="17" ids="53093">DTC</z:chebi>, carcinoembryonic antigen (CEA) and survivin </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The frequencies of <z:chebi fb="17" ids="53093">DTC</z:chebi> detected in PB and BM were 52.0% (39/75) and 29.3% (22/75) respectively, and showed no correlations with each other (p&gt;0.05), their combination increased the sensitivity to 65.3% (49/75) </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, <z:chebi fb="17" ids="53093">DTC</z:chebi> positive either in PB or BM was correlated with lymph <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, advanced stage and adverse 2-year progression free survival (PFS) </plain></SENT>
<SENT sid="6" pm="."><plain>In a multivariate analysis using the Cox proportional hazard model, <z:chebi fb="17" ids="53093">DTC</z:chebi> positive in PB and/ or BM was an independent unfavorable prognostic factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> apart from lymph <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and adjuvant chemotherapy </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: CEA and/or survivin-positive <z:chebi fb="17" ids="53093">DTCs</z:chebi> may be a promising biomarker for prognosis assessment in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>